Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • May 2019
  • Global
  • 188 Pages
  • No of Tables: 28
  • No of Figures: 214

Global Rx Dermatology Topical Drug Delivery Market By Product Type (Semi-Solid, Liquid, Solid), Application (Skin Infections, Dermatitis, Antiaging, Acne, Hyperpigmentation, Rosacea, Skin Cancer, Psoriasis, Onychomycosis, Others), Category (Branded, Generic), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2026

Topical drugs play an important role in the therapy of dermatologic diseases. Topical dermatology drugs frame a large percentage of products in the drug market. These products are manufactured through specialized manufacturing processes such as precise volume filling, large scale mixing and heating and packaging.

Topical drug administration can be done in the body through ophthalmic, rectal, vaginal and skin as topical routes. In dermatology sector, skin plays a major role for the administration of topical drug for the treatment of skin disease in patients. The topical preparations are applied on the skin for surface, local or systemic effects. The topical formulations include therapeutically active ingredients which help in treating the skin diseases in patients.

Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired unfavourable effect of a drug is dependent on the concentration of the drug at the place of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action. In dermatology sector, drug molecule applied on the skin which penetrates the skin primarily through the tortuous and continuous intercellular path. These products are available in different forms such as ointments, creams, lotions, gels and others which have the ability to get absorbed in the body and show the positive response in healing wound respectively.

Global Rx dermatology topical drug delivery market is expected to register a healthy CAGR of 4.2% in the forecast period of 2019-2026.

Segmentation: Global Rx Dermatology Topical Drug Delivery Market

The global Rx dermatology topical drug delivery market is segmented on the basis product type, application, and category.

  • On the basis of product type, the market is segmented into solid, liquid and semi-solid. Solid is sub-segmented into powder and others. Liquid is sub-segmented into solution, emulsion, suspension, lotion and others. Semisolid is sub-segmented into creams, gel, ointments, paste, others.

    • In December 2016, Pfizer Inc. received approval from U.S. Food and Drug Administration (FDA) for the product called EUCRISATM (crisaborole) ointment 2%. It is a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor. It is used for the treatment of mild to moderate atopic dermatitis (AD). With this launch of the product the company has built a heritage in Inflammation and Immunology sector.

  • On the basis of application, the market is segmented into acne, dermatitis, psoriasis, skin infections, antiaging, skin cancer, hyperpigmentation, onychomycosis, rosacea, others.

    • In March 2017, Galderma Laboratories, L.P., makers of Cetaphil brand launched seven new facial skincare products. With this launch of the products Cetaphil portfolio of the company has increased. The company has now broad range of specialized solutions for the patients with skin concerns, including hydration and others.

  • On the basis of category, the market is segmented into generic and branded.

    • In February 2016, Allergan plc received an approval for its product ACZONE (dapsone) Gel, 7.5% from the U.S. Food and Drug Administration (FDA). This product is a new prescription topical treatment which is useful for the treatment of acne in patients 12 years of age and older. The product helped patient in treating acne easily which ultimately helped in increase in revenue.

Competitive Analysis: Global Rx Dermatology Topical Drug Delivery Market

Some of the prominent participants operating in this market are Galderma Laboratories, L.P., Hisamitsu Pharmaceutical Co., Inc., Pfizer Inc., LEO Pharma A/S, GlaxoSmithKline plc., ALLERGAN, Bayer AG, 3M, Bausch Health Companies Inc., The Lubrizol Corporation, Cipla Inc., Kaken Pharmaceutical Co.,Ltd. among others.

Recent Developments:

  • In April 2016, Allergan plc acquired Topokine Therapeutics, Inc. with upfront payment of USD 85.8 million and was eligible to receive contingent development and commercialization milestones of up to USD 260.0 million.
  • In February 2019, Kaken Pharmaceutical Co., Ltd. has concluded an exclusive license and distribution agreement for the topical formulation for Onychomycosis in the People’s Republic of China. According to the agreement Kaken Pharmaceutical Co., Ltd., provided exclusive right for the development and commercialization of the Product in PRC and this has led in high revenue generation.
  • In April 2019, The Lubrizol Corporation launched its newest multifunctional, 2- in-1 rheology modifier, Carbopol Style 2.0 polymer. The product has the benefits for the skin care such as smooth glossy appearance, unique formulation textures and others. With this launch the product portfolio of the company has increased which resulted higher revenue generation.
  • In August 2018, Cipla INC. received final approval for Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel, 1% from the U.S. Food and Drug Administration (US FDA). Due to this the company has increased their product portfolio and strong position in market especially in dermatology field.
  • In November 2010, 3M re-launched Cavilon Professional Skin Care line. This product helped in preventing skin damage from moisture, friction and adhesive trauma. The product portfolio of the company has increased in dermatology filed and hence increased healthcare revenue.

Research Methodology: Global Rx Dermatology Topical Drug Delivery Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Pharmaceutical & Biotechnological Researchers, Doctors & Nurses.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

LIST OF TABLES GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET

TABLE 1 NUMBER OF FORMULATION COMPONENTS FOR TOPICAL DRUG PRODUCTS MENTIONED BELOW: TABLE 2 NUMBER AND DISTRIBUTION OF PERSONS AGED 60 YEARS OR OVER BY REGION, IN 2017 AND 2050 TABLE 3 LIST OF APPROVED TOPICAL DRUGS TABLE 4 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2017-2026 (USD MILLION) TABLE 5 GLOBAL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 GLOBAL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 7 GLOBAL SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 GLOBAL SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 9 GLOBAL LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 10 GLOBAL LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 11 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION , 2017-2026 (USD MILLION) TABLE 12 GLOBAL SKIN INFECTIONS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 GLOBAL DERMATITIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 GLOBAL ANTIAGING IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 GLOBAL ACNE IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 GLOBAL HYPERPIGMENTATION IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 GLOBAL ROSACEA IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 18 GLOBAL SKIN CANCER IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 GLOBAL PSORIASIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 GLOBAL ONYCHOMYCOSIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 21 GLOBAL OTHERS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY , 2017-2026 (USD MILLION) TABLE 23 GLOBAL BRANDED IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 GLOBAL GENERIC IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 26 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 27 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 28 NORTH AMERICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 29 NORTH AMERICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 30 NORTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 31 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 32 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 33 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 34 U.S. SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 35 U.S. LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 36 U.S. SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 37 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 38 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 39 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 40 CANADA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 41 CANADA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 42 CANADA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 43 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 44 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 45 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 46 MEXICO SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 47 MEXICO LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 48 MEXICO SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 49 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 50 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 51 EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 52 EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 53 EUROPE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 54 EUROPE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 55 EUROPE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 56 EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 57 EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 58 GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 59 GERMANY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 60 GERMANY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 61 GERMANY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 62 GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 63 GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 64 FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 65 FRANCE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 66 FRANCE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 67 FRANCE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 68 FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 69 FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 70 ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 71 ITALY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 72 ITALY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 73 ITALY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 74 ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 76 U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 77 U.K. SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 78 U.K. LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 79 U.K. SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 80 U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 81 U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 82 SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 83 SWITZERLAND SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 84 SWITZERLAND LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 85 SWITZERLAND SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 86 SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 87 SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 88 SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 89 SPAIN SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 90 SPAIN LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 91 SPAIN SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 92 SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 93 SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 94 NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 95 NETHERLANDS SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 96 NETHERLANDS LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 97 NETHERLANDS SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 98 NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 99 NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 100 RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 101 RUSSIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 102 RUSSIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 103 RUSSIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 104 RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 105 RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 106 TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 107 TURKEY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 108 TURKEY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 109 TURKEY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 110 TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 111 TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 112 BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 113 BELGIUM SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 114 BELGIUM LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 115 BELGIUM SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 116 BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 117 BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 118 REST OF EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 119 ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 120 ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 121 ASIA-PACIFIC SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 122 ASIA-PACIFIC LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 123 ASIA-PACIFIC SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 124 ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 125 ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 126 JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 127 JAPAN SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 128 JAPAN LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 129 JAPAN SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 130 JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 131 JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 132 CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 133 CHINA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 134 CHINA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 135 CHINA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 136 CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 137 CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 138 INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 139 INDIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 140 INDIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 141 INDIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 142 INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 143 INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 144 SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 145 SOUTH KOREA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 146 SOUTH KOREA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 147 SOUTH KOREA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 148 SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 149 SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 150 AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 151 AUSTRALIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 152 AUSTRALIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 153 AUSTRALIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 154 AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 155 AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 156 THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 157 THAILAND SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 158 THAILAND LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 159 THAILAND SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 160 THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 161 THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 162 MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 163 MALAYSIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 164 MALAYSIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 165 MALAYSIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 166 MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 167 MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 168 SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 169 SINGAPORE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 170 SINGAPORE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 171 SINGAPORE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 172 SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 173 SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 174 INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 175 INDONESIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 176 INDONESIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 177 INDONESIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 178 INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 179 INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 180 PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 181 PHILIPPINES SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 182 PHILIPPINES LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 183 PHILIPPINES SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 184 PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 185 PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 186 REST OF ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 187 SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 188 SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 189 SOUTH AMERICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 190 SOUTH AMERICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 191 SOUTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 192 SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 193 SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 194 BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 195 BRAZIL SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 196 BRAZIL LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 197 BRAZIL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 198 BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 199 BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 200 REST OF SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 201 MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 202 MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 203 MIDDLE EAST & AFRICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 204 MIDDLE EAST & AFRICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 205 MIDDLE EAST & AFRICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 206 MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 207 MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 208 SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 209 SOUTH AFRICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 210 SOUTH AFRICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 211 SOUTH AFRICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) TABLE 212 SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 213 SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION) TABLE 214 REST OF SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19